Skip to main content
Erschienen in: Neurotoxicity Research 2/2011

01.02.2011

Staging Bipolar Disorder

verfasst von: Eduard Vieta, M. Reinares, A. R. Rosa

Erschienen in: Neurotoxicity Research | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to analyze the evidence supporting a staging model for bipolar disorder. The authors conducted an extensive Medline and Pubmed search of the published literature using a variety of search terms (staging, bipolar disorder, early intervention) to find relevant articles, which were reviewed in detail. Only recently specific proposals have been made to apply clinical staging to bipolar disorder. The staging model in bipolar disorder suggests a progression from prodromal (at-risk) to more severe and refractory presentations (Stage IV). A staging model implies a longitudinal appraisal of different aspects: clinical variables, such as number of episodes and subsyndromal symptoms, functional and cognitive impairment, comorbidity, biomarkers, and neuroanatomical changes. Staging models are based on the fact that response to treatment is generally better when it is introduced early in the course of the illness. It assumes that earlier stages have better prognosis and require simpler therapeutic regimens. Staging may assist in bipolar disorder treatment planning and prognosis, and emphasize the importance of early intervention. Further research is required in this exciting and novel area.
Literatur
Zurück zum Zitat Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA, Kapczinski F (2007) DNA damage in bipolar disorder. Psychiatry Res 53:27–32CrossRef Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA, Kapczinski F (2007) DNA damage in bipolar disorder. Psychiatry Res 53:27–32CrossRef
Zurück zum Zitat Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, Walz JC, Bond DJ, Gonçalves CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Neuroscience 34:263–271 Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, Walz JC, Bond DJ, Gonçalves CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Neuroscience 34:263–271
Zurück zum Zitat Berk M, Hallam KT, McGorry PD (2007a) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100:279–281CrossRefPubMed Berk M, Hallam KT, McGorry PD (2007a) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100:279–281CrossRefPubMed
Zurück zum Zitat Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P (2007b) Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9:671–678CrossRefPubMed Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P (2007b) Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9:671–678CrossRefPubMed
Zurück zum Zitat Berk M, Malhi GS, Hallam K, Gama CS, Dodd S, Andreazza AC, Frey BN, Kapczinski F (2009) Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord 114:1–13CrossRefPubMed Berk M, Malhi GS, Hallam K, Gama CS, Dodd S, Andreazza AC, Frey BN, Kapczinski F (2009) Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord 114:1–13CrossRefPubMed
Zurück zum Zitat Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS (2006) Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 59:611–618CrossRefPubMed Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS (2006) Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 59:611–618CrossRefPubMed
Zurück zum Zitat Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E (in press) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E (in press) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord
Zurück zum Zitat Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1355–1361CrossRefPubMed Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1355–1361CrossRefPubMed
Zurück zum Zitat Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116:214–217CrossRefPubMed Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116:214–217CrossRefPubMed
Zurück zum Zitat Colom F, Vieta E (2009) The road to DSM-V: bipolar disorder episode and course specifiers. Psychopathology 42:209–218CrossRefPubMed Colom F, Vieta E (2009) The road to DSM-V: bipolar disorder episode and course specifiers. Psychopathology 42:209–218CrossRefPubMed
Zurück zum Zitat Colom F, Reinares M, Pachiarotti I, Mazzarini L, Martínez-Arán A, Torrent C, Rosa A, Palomino-Otiniano R, Franco C, Bonnín C, Vieta E (in press) Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post-hoc analysis. Acta Neuropsychiatrica Colom F, Reinares M, Pachiarotti I, Mazzarini L, Martínez-Arán A, Torrent C, Rosa A, Palomino-Otiniano R, Franco C, Bonnín C, Vieta E (in press) Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post-hoc analysis. Acta Neuropsychiatrica
Zurück zum Zitat Conus P, Berk M, McGorry PD (2006) Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Aust N Z J Psychiatry 40:199–207PubMed Conus P, Berk M, McGorry PD (2006) Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Aust N Z J Psychiatry 40:199–207PubMed
Zurück zum Zitat Correll CU, Penzner JB, Lencz T, Auther A, Smith CW, Maalhotra AK, Kane JM, Cornblatt BA (2007) Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 9:324–338CrossRefPubMed Correll CU, Penzner JB, Lencz T, Auther A, Smith CW, Maalhotra AK, Kane JM, Cornblatt BA (2007) Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 9:324–338CrossRefPubMed
Zurück zum Zitat Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gervin M, McTigue O, Kinsella A, Waddington JL, Larkin C, O’Callaghan E (2009) Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br J Psychiatry 194:18–24CrossRefPubMed Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Gervin M, McTigue O, Kinsella A, Waddington JL, Larkin C, O’Callaghan E (2009) Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br J Psychiatry 194:18–24CrossRefPubMed
Zurück zum Zitat Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, Santin A, Kapczinski F (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398:215–219CrossRefPubMed Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Gonçalves CA, Santin A, Kapczinski F (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398:215–219CrossRefPubMed
Zurück zum Zitat Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Gonçalves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258:300–304CrossRefPubMed Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Gonçalves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258:300–304CrossRefPubMed
Zurück zum Zitat Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121:127–135CrossRefPubMed Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121:127–135CrossRefPubMed
Zurück zum Zitat Fava GA, Kellner R (1993) Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 87:225–230CrossRefPubMed Fava GA, Kellner R (1993) Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 87:225–230CrossRefPubMed
Zurück zum Zitat Franchini L, Zanardi R, Smeraldi E, Gasperini M (1999) Early onset of lithium propylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 249:227–230CrossRefPubMed Franchini L, Zanardi R, Smeraldi E, Gasperini M (1999) Early onset of lithium propylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 249:227–230CrossRefPubMed
Zurück zum Zitat Frey BN, Andreazza AC, Ceresér KM, Martins MR, Valvassori SS, Réus GZ, Quevedo J, Kapczinski F (2006) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281–286CrossRefPubMed Frey BN, Andreazza AC, Ceresér KM, Martins MR, Valvassori SS, Réus GZ, Quevedo J, Kapczinski F (2006) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281–286CrossRefPubMed
Zurück zum Zitat Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM (2008a) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675–692CrossRefPubMed Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM (2008a) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675–692CrossRefPubMed
Zurück zum Zitat Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’Anna M, Cunha AB, Post RM (2008b) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30:243–245PubMed Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’Anna M, Cunha AB, Post RM (2008b) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30:243–245PubMed
Zurück zum Zitat Kapczinski F, Vasco D, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009a) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957–966CrossRefPubMed Kapczinski F, Vasco D, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009a) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957–966CrossRefPubMed
Zurück zum Zitat Kapczinski F, Dias VV, Kauer-Sant’anna M, Brietzke E, Vázquez GH, Vieta E, Berk M (2009b) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1366–1371CrossRefPubMed Kapczinski F, Dias VV, Kauer-Sant’anna M, Brietzke E, Vázquez GH, Vieta E, Berk M (2009b) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 33:1366–1371CrossRefPubMed
Zurück zum Zitat Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain derived neurotrophic factor and inflammatory markers in patients with early- vs. late stage bipolar disorder. Int J Neuropsychopharmacol 12:447–458CrossRefPubMed Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain derived neurotrophic factor and inflammatory markers in patients with early- vs. late stage bipolar disorder. Int J Neuropsychopharmacol 12:447–458CrossRefPubMed
Zurück zum Zitat Kessing LV, Mortensen PB, Bolwig TG (1998) Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord 47:31–39CrossRefPubMed Kessing LV, Mortensen PB, Bolwig TG (1998) Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord 47:31–39CrossRefPubMed
Zurück zum Zitat Kessing LV, Hansen MG, Andersen PK, Angst J (2004) The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders—a life-long perspective. Acta Psychiatr Scand 109:339–344CrossRefPubMed Kessing LV, Hansen MG, Andersen PK, Angst J (2004) The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders—a life-long perspective. Acta Psychiatr Scand 109:339–344CrossRefPubMed
Zurück zum Zitat Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M (2006) Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry 67:95–101CrossRefPubMed Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M (2006) Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry 67:95–101CrossRefPubMed
Zurück zum Zitat Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee JY, Kim SJ, Kim N, Dunner DL, Renshaw PF (2006) Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 8:65–74CrossRefPubMed Lyoo IK, Sung YH, Dager SR, Friedman SD, Lee JY, Kim SJ, Kim N, Dunner DL, Renshaw PF (2006) Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 8:65–74CrossRefPubMed
Zurück zum Zitat Martínez-Arán A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares-Seisdedos R, Ayuso-Mateos JL (2007) Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 9:103–113CrossRefPubMed Martínez-Arán A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, Malhi GS, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Kaprinis G, Tabares-Seisdedos R, Ayuso-Mateos JL (2007) Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 9:103–113CrossRefPubMed
Zurück zum Zitat McElroy SL, Altshuler LL, Suppes T, Keck PE Jr, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158:420–426CrossRefPubMed McElroy SL, Altshuler LL, Suppes T, Keck PE Jr, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158:420–426CrossRefPubMed
Zurück zum Zitat McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164:859–860CrossRefPubMed McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164:859–860CrossRefPubMed
Zurück zum Zitat McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40:616–622PubMed McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40:616–622PubMed
Zurück zum Zitat McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7:148–156PubMed McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7:148–156PubMed
Zurück zum Zitat Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176CrossRefPubMed Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176CrossRefPubMed
Zurück zum Zitat Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2007) Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62:894–900CrossRefPubMed Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2007) Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62:894–900CrossRefPubMed
Zurück zum Zitat Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436–1442CrossRefPubMed Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349:1436–1442CrossRefPubMed
Zurück zum Zitat Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999–1010PubMed Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999–1010PubMed
Zurück zum Zitat Post RM, Rubinow DR, JC Ballenger (1986) Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 149:191–201CrossRefPubMed Post RM, Rubinow DR, JC Ballenger (1986) Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 149:191–201CrossRefPubMed
Zurück zum Zitat Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, Kapczinski F, Vieta E (2010) The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 123:81–86CrossRefPubMed Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, Kapczinski F, Vieta E (2010) The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 123:81–86CrossRefPubMed
Zurück zum Zitat Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8:103–116CrossRefPubMed Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8:103–116CrossRefPubMed
Zurück zum Zitat Rosa AR, Frey BN, Andreazza AC, Ceresér KM, Cunha AB, Quevedo J, Santin A, Gottfried C, Gonçalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407:146–150CrossRefPubMed Rosa AR, Frey BN, Andreazza AC, Ceresér KM, Cunha AB, Quevedo J, Santin A, Gottfried C, Gonçalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407:146–150CrossRefPubMed
Zurück zum Zitat Rosa AR, Reinares M, Franco C, Comes M, Torrent C, Sánchez-Moreno J, Martínez-Arán A, Salamero M, Kapczinski F, Vieta E (2009) Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 11:401–409CrossRefPubMed Rosa AR, Reinares M, Franco C, Comes M, Torrent C, Sánchez-Moreno J, Martínez-Arán A, Salamero M, Kapczinski F, Vieta E (2009) Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 11:401–409CrossRefPubMed
Zurück zum Zitat Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK (2008a) Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Interv Psychiatry 2:122–135CrossRefPubMed Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK (2008a) Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Interv Psychiatry 2:122–135CrossRefPubMed
Zurück zum Zitat Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK (2008b) Early intervention in bipolar disorder, part II: therapeutics. Early Interv Psychiatry 2:136–146CrossRefPubMed Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK (2008b) Early intervention in bipolar disorder, part II: therapeutics. Early Interv Psychiatry 2:136–146CrossRefPubMed
Zurück zum Zitat Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 188:310–320 Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 188:310–320
Zurück zum Zitat Silverstone T, McPherson H, Li Q, Doyle T (2003) Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 5:53–57CrossRefPubMed Silverstone T, McPherson H, Li Q, Doyle T (2003) Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 5:53–57CrossRefPubMed
Zurück zum Zitat Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60:432–435CrossRefPubMed Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60:432–435CrossRefPubMed
Zurück zum Zitat Soares JC, Kochunov P, Monkul ES, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Lancaster J, Fox P (2005) Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16:541–544CrossRefPubMed Soares JC, Kochunov P, Monkul ES, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Lancaster J, Fox P (2005) Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16:541–544CrossRefPubMed
Zurück zum Zitat Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159:1841–1847CrossRefPubMed Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159:1841–1847CrossRefPubMed
Zurück zum Zitat Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (1999) Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 156:1264–1266PubMed Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (1999) Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 156:1264–1266PubMed
Zurück zum Zitat Torres IJ, Boudreau VG, Yatham LN (2007) Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl (434):17–26 Torres IJ, Boudreau VG, Yatham LN (2007) Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl (434):17–26
Zurück zum Zitat Vieta E, Phillips ML (2007) Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull 33:886–892CrossRefPubMed Vieta E, Phillips ML (2007) Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull 33:886–892CrossRefPubMed
Zurück zum Zitat Vieta E, Popovic D, Rosa AR, Solé B, Grande I, Frey BN, Martínez-Arán A, Kapczinski F (in press) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. J Affect Disord Vieta E, Popovic D, Rosa AR, Solé B, Grande I, Frey BN, Martínez-Arán A, Kapczinski F (in press) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. J Affect Disord
Zurück zum Zitat Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM, Cunha AB, Weyne F, Stertz L, Santin A, Gonçalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415:87–89CrossRefPubMed Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM, Cunha AB, Weyne F, Stertz L, Santin A, Gonçalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415:87–89CrossRefPubMed
Zurück zum Zitat Walz JC, Magalhães PV, Giglio LM, Cunha AB, Stertz L, Fries GR, Andreazza AC, Kapczinski F (2009) Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res 43:721–723CrossRefPubMed Walz JC, Magalhães PV, Giglio LM, Cunha AB, Stertz L, Fries GR, Andreazza AC, Kapczinski F (2009) Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res 43:721–723CrossRefPubMed
Zurück zum Zitat Yatham LN, Kapczinski F, Andreazza AC, Trevor Young L, Lam RW, Kauer-Sant’anna M (2009) Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12:137–139CrossRefPubMed Yatham LN, Kapczinski F, Andreazza AC, Trevor Young L, Lam RW, Kauer-Sant’anna M (2009) Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12:137–139CrossRefPubMed
Metadaten
Titel
Staging Bipolar Disorder
verfasst von
Eduard Vieta
M. Reinares
A. R. Rosa
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Neurotoxicity Research / Ausgabe 2/2011
Print ISSN: 1029-8428
Elektronische ISSN: 1476-3524
DOI
https://doi.org/10.1007/s12640-010-9197-8

Weitere Artikel der Ausgabe 2/2011

Neurotoxicity Research 2/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.